Novo Nordisk’s Wegovy reduces risk of adverse cardiovascular events by 20% in obese adults By: MarketWatch August 08, 2023 at 07:29 AM EDT Obesity drug shows positive results in tackling some of the other illnesses caused by being overweight. Read More >> Related Stocks: Eli Lilly Novo Nordisk A/S ADR Pfizer
